← Back to Search

Inje Cocktail + THC extract for Drug Interaction

Phase 1
Waitlist Available
Led By Ryan Vandrey, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

This trial will study how cannabis affects other drugs people may be taking.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Drug Effect Questionnaire (DEQ) - Peak Score for Feel Drug Effect
Losartan Area Under the Curve (AUC) in Plasma
Number of Correct Trials on the Digit Symbol Substitution Task (DSST)
+3 more
Secondary outcome measures
Caffeine AUC in Plasma
Dextromethorphan AUC in Plasma
Midazolam AUC in Plasma
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Inje Cocktail + THC/CBD extractExperimental Treatment2 Interventions
Single oral administration of Inje Cocktail + brownie infused with cannabis extract containing 20mg THC and 640mg CBD
Group II: Inje Cocktail + THC extractExperimental Treatment2 Interventions
Single oral administration of Inje Cocktail + brownie infused with cannabis extract containing 20mg THC
Group III: Inje CocktailActive Control1 Intervention
Single oral administration of caffeine (100mg), omeprazole (20mg), losartan (25mg), dextromethorphan (30mg), and midazolam (1mg)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Inje cocktail
2020
Completed Phase 1
~30
THC/CBD Cannabis Extract
2020
Completed Phase 1
~30
THC Cannabis extract
2020
Completed Phase 1
~30

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,267 Previous Clinical Trials
14,837,585 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
835 Previous Clinical Trials
669,518 Total Patients Enrolled
Washington State UniversityOTHER
102 Previous Clinical Trials
56,720 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs
2020. "Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04201197.
~5 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top